Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid
NCT07210554
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Bullous Pemphigoid (BP)
Interventions
BIOLOGICAL:
Stapokibart injection
DRUG:
Placebo
Sponsor
Chengdu Kangnuoxing Biopharma,Inc.